510(k) device
Quex Ed
Qx World, Ltd. · Reduced- Montage Standard Electroencephalograph (OMC, Class II) · First FDA decision Oct 11, 2024, newest Oct 11, 2024Epilepsy
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
1
Naming "Quex Ed"
MAUDE reports
0
Brand "Quex Ed", since 2015
PubMed studies
0
Mentioning "Quex Ed"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Quex Ed
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- QUEX ED; QUEX S510(k)
K232779 · Decided Oct 11, 2024 · 396 days after receipt
Device type: Reduced- Montage Standard Electroencephalograph (OMC) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Quex Ed", any status and sponsor, newest update first.
Kasey PhiferAcademic, hospital or other
NCT04577053 · 20 participants · Start Oct 7, 2020 · Primary completion Dec 4, 2020
Device: Scientific Consciousness Interface Operations (SCIO) Class II FDA approved medical device · For: Lyme Disease; Lyme Neuroborreliosis; Lyme Arthritis and 1 more
Sites: Bristol, United Kingdom; Weston, United Kingdom
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Quex Ed", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OMC
8 reports: 6 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Quex Ed"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OMC.
- SignalNED System (Model RE)Forest Devices, Inc. · 510(k) 2025
- REMI Remote EEG Monitoring SystemEpitel · 510(k) 2025
- Ceribell MonitorCeribell, Inc. · 510(k) 2026
- NX01 (NX01)Naox Technologies Sas · 510(k) 2025
- Natus BrainWatch SystemNatus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · 510(k) 2024
- NEBA® Compact EEG2R Mobile HeadsetNeba Health, LLC · 510(k) 2023
- Neurosteer EEG RecorderNeurosteer, Inc. · 510(k) 2022
- RemiEpitel, Inc. · 510(k) 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.